Back to Journals » Therapeutics and Clinical Risk Management » Volume 14
Original Research
Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,425 | Dovepress* | 7,826+ | 1,315 | 9,141 | |
PubMed Central* | 599 | 165 | 764 | ||
Totals | 8,425 | 1,480 | 9,905 | ||
*Since 4 May 2018 |
View citations on PubMed Central and Google Scholar